Summit Therapeutics PLC(SMMT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SMMT Summit Therapeutics PLC

盘后交易 04-29 16:15:38 EDT

20.83

-0.43

-2.02%

盘后20.83

+0.000.00%

16:10 EDT

最高21.61	最低20.55	成交量275.53万
今开21.61	昨收21.26	日振幅4.99%
总市值161.51亿	流通市值26.87亿	总股本7.75亿
成交额5,741万	换手率2.14%	流通股本1.29亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"SMMT","market":"US","secType":"STK","nameCN":"Summit Therapeutics PLC","latestPrice":20.83,"timestamp":1777492800000,"preClose":21.26,"halted":0,"volume":2755303,"hourTrading":{"tag":"盘后","latestPrice":20.83,"preClose":20.83,"latestTime":"16:10 EDT","volume":36014,"amount":750106.146548,"timestamp":1777493405162,"change":0,"changeRate":0,"amplitude":0.008512},"delay":0,"changeRate":-0.020225776105362334,"floatShares":129000000,"shares":775372700,"eps":-1.44,"marketStatus":"盘后交易","change":-0.43,"latestTime":"04-29 16:15:38 EDT","open":21.61,"high":21.61,"low":20.55,"amount":57410565.828372,"amplitude":0.049859,"askPrice":21,"askSize":8,"bidPrice":20.66,"bidSize":14,"shortable":3,"etf":0,"ttmEps":-1.44,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1777507200000},"marketStatusCode":4,"adr":1,"adrRate":5,"listingDate":1425531600000,"exchange":"NASDAQ","adjPreClose":21.26,"preHourTrading":{"tag":"盘前","latestPrice":21.28,"preClose":21.26,"latestTime":"09:29 EDT","volume":9925,"amount":212110.698375,"timestamp":1777469399999,"change":0.02,"changeRate":0.000941,"amplitude":0.032926},"postHourTrading":{"tag":"盘后","latestPrice":20.83,"preClose":20.83,"latestTime":"16:10 EDT","volume":36014,"amount":750106.146548,"timestamp":1777493405162,"change":0,"changeRate":0,"amplitude":0.008512},"volumeRatio":0.548143,"impliedVol":1.3863,"impliedVolPercentile":0.988},"requestUrl":"/m/hq/s/SMMT","defaultTab":"news","newsList":[{"id":"2622426438","title":"英国汽车制造商和贸易商协会：出口疲软导致英国2月汽车产量大幅下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2622426438","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622426438?lang=zh_cn&edition=full","pubTime":"2026-03-27 17:30","pubTimestamp":1774603800,"startTime":"0","endTime":"0","summary":"英国汽车制造商和贸易商协会数据显示，英国2月汽车产量大幅下滑，这凸显出该行业面临的压力日益加剧，而此时伊朗冲突尚未给英国制造业前景蒙上更深层的阴影。　　该协会数据显示，英国汽车产量同比下降17.2%，至68061辆。　　协会数据同时显示，欧盟仍是英国汽车工厂全球最大的出口市场，吸纳了英国64%的汽车出口量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/world/2026-03-27/doc-inhsmnzv8304933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SMMT","LU2488822045.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107476933","title":"Summit Therapeutics盘前大涨5.5% 美国FDA受理其Ivonescimab上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1107476933","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107476933?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:36","pubTimestamp":1769690215,"startTime":"0","endTime":"0","summary":"Summit Therapeutics PLC股价在盘前交易中强势攀升5.5%，此前美国食品药品监督管理局正式受理了该公司提交的双特异性抗体药物Ivonescimab的新药上市申请。\n这一关键监管里程碑的达成，为这款创新肿瘤免疫疗法的审评进程铺平了道路，同时也显著提振了市场投资者对该公司未来发展前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMT","LU2488822045.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142715038","title":"Summit Therapeutics宣布美国FDA受理Ivonescimab联合化疗治疗EGFR突变非小细胞肺癌患者TKI治疗后生物制品许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1142715038","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142715038?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:31","pubTimestamp":1769689877,"startTime":"0","endTime":"0","summary":"Summit Therapeutics PLC宣布，美国食品药品监督管理局（FDA）已正式受理其提交的生物制品许可申请（BLA）。该申请旨在寻求批准Ivonescimab与化疗联合，用于治疗表皮生长因子受体（EGFR）突变的非小细胞肺癌（NSCLC）患者，这些患者此前已接受过酪氨酸激酶抑制剂（TKI）治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK4139","SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190691688","title":"Summit Therapeutics：双方保留各自产品权益，协议具有双向非排他性","url":"https://stock-news.laohu8.com/highlight/detail?id=1190691688","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190691688?lang=zh_cn&edition=full","pubTime":"2026-01-12 19:18","pubTimestamp":1768216682,"startTime":"0","endTime":"0","summary":"根据最新合作协议条款，Summit Therapeutics PLC（以下简称Summit）与其合作伙伴将保持对各自研发产品的完整所有权。该协议采用双向非排他性模式，意味着双方均可独立开展与其他实体的合作，同时保留对自有知识产权的绝对控制权。\n这一安排既保障了双方在特定领域的自主运营空间，又为未来潜在的战略协同留下弹性。非排他性条款尤其凸显了合作框架的灵活性，允许各方在遵守协议基础上自由探索多元化的商业机会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064927863.SGD","LU0306807586.USD","LU1228905037.USD","LU0545562505.USD","BK4139","LU0211331839.USD","LU0971552673.USD","LU0203347892.USD","LU0985481810.HKD","LU1015430645.USD","SMMT","IE00B3T34201.USD","LU1400636491.USD","LU1098665638.USD","LU0203345920.USD","LU0289739699.SGD","LU0109981661.USD","LU0058720904.USD","LU1481600234.SGD","IE0034235071.USD","LU1983299246.USD","LU0225284248.USD","LU1228905540.USD","IE00BQJZX424.USD","LU0321505439.SGD","LU1487256676.USD","LU1302929846.USD","LU1309081286.SGD","LU1645745479.HKD","LU1400636657.SGD","LU0971552830.HKD","LU1670756490.USD","LU2488822045.USD","LU1481599808.USD","LU0321505868.SGD","LU0161305163.EUR","LU1046248800.SGD","LU1202635105.USD","LU0225771236.USD","IE00BWDBJ516.SGD","BK5011","LU0306806265.USD","LU1400636574.HKD","GSK.UK","LU1035777561.USD","LU0575583348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601485265","title":"50亿英镑折扣撬动市场！英国2025年新车销量重回200万辆 中国品牌加速崛起","url":"https://stock-news.laohu8.com/highlight/detail?id=2601485265","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601485265?lang=zh_cn&edition=full","pubTime":"2026-01-06 10:25","pubTimestamp":1767666309,"startTime":"0","endTime":"0","summary":"英国汽车制造商和贸易商协会周二公布的数据显示，2025年新车注册量增长3.5%，达到202万辆。中国汽车日益增长的受欢迎度助力英国汽车销量重回200万辆以上水平，其更亲民的价格吸引了消费者。英国对中国品牌尤其具有吸引力，因为它没有效仿欧盟对中国制造的电动汽车加征关税。这家英国最大的汽车制造商被迫停产近六周，促使政府出面提供15亿英镑的紧急贷款担保，以帮助陷入困境的供应商。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SMMT","LU2488822045.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158928922","title":"Summit Therapeutics申请最多2670万股普通股的配售 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1158928922","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158928922?lang=zh_cn&edition=full","pubTime":"2025-10-30 05:14","pubTimestamp":1761772463,"startTime":"0","endTime":"0","summary":"Summit Therapeutics申请最多2670万股普通股的配售，售出股东将在SEC备案中进行披露。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2488822045.USD","SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518436278","title":"Summit Therapeutics Inc.盘中异动 股价大跌5.91%报16.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518436278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518436278?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613469,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Summit Therapeutics Inc.股票出现异动，股价急速跳水5.91%。截至发稿，该股报16.73美元/股，成交量9.1706万股，换手率0.01%，振幅0.81%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.59%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021310998a29c8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021310998a29c8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","LU2488822045.USD","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517516510","title":"Summit Therapeutics Inc.盘中异动 早盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517516510","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517516510?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:34","pubTimestamp":1741271643,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时34分，Summit Therapeutics Inc.股票出现波动，股价急速下跌5.06%。截至发稿，该股报18.56美元/股，成交量5.6688万股，换手率0.01%，振幅2.05%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.64%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223403abeb7870&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223403abeb7870&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","LU2488822045.USD","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516650980","title":"Summit Therapeutics Inc.盘中异动 急速下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516650980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516650980?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:36","pubTimestamp":1741030563,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时36分，Summit Therapeutics Inc.股票出现异动，股价快速下跌5.12%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4550.84%、206.83%、181.58%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040336039637f047&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040336039637f047&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SMMT","LU2488822045.USD","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514376555","title":"Summit Therapeutics Inc.盘中异动 早盘大幅拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514376555?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:26","pubTimestamp":1740756399,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时26分，Summit Therapeutics Inc.股票出现异动，股价急速拉升5.08%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Bioxcel Therapeutics, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Puma Biotechnology Inc涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为1430.83%、405.61%、337.95%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Bioxcel Therapeutics, Inc.，振幅分别为46.60%、43.37%、38.73%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228232639a2580f75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228232639a2580f75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","LU2488822045.USD","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514238400","title":"Summit Therapeutics Inc.2024财年实现净利润-2.21亿美元，同比增加64.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514238400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514238400?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:01","pubTimestamp":1740672061,"startTime":"0","endTime":"0","summary":"2月28日，Summit Therapeutics Inc.公布财报，公告显示公司2024财年净利润为-2.21亿美元，同比增加64.07%；其中营业收入为0.00美元，每股基本收益为-0.31美元。机构评级：截至2025年2月28日，当前有6家机构对Summit Therapeutics Inc.目标价做出预测，其中目标均价为35.33美元，其中最低目标价为30.00美元，最高目标价为44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000106abdf84f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228000106abdf84f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SMMT","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514867183","title":"Summit Therapeutics Inc.盘中异动 大幅上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514867183","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514867183?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666751,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Summit Therapeutics Inc.股票出现异动，股价急速拉升5.22%。截至发稿，该股报19.26美元/股，成交量5.4943万股，换手率0.01%，振幅3.20%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223231a2567a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223231a2567a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LU2488822045.USD","BK4139","SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514851874","title":"Summit Therapeutics Inc.盘中异动 早盘股价大涨5.30%报19.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514851874?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:51","pubTimestamp":1740581499,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时51分，Summit Therapeutics Inc.股票出现异动，股价大幅拉升5.30%。截至发稿，该股报19.07美元/股，成交量19.9915万股，换手率0.03%，振幅3.75%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225139a254fbaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226225139a254fbaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","SMMT","LU2488822045.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514155760","title":"Summit Therapeutics Inc.盘中异动 早盘快速下跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514155760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514155760?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:14","pubTimestamp":1740496489,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时14分，Summit Therapeutics Inc.股票出现异动，股价大幅下跌5.07%。截至发稿，该股报17.89美元/股，成交量95.9436万股，换手率0.13%，振幅6.37%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523144998925689&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523144998925689&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LU2488822045.USD","SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514072060","title":"一次宇宙级合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2514072060","media":"瞪羚社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514072060?lang=zh_cn&edition=full","pubTime":"2025-02-25 20:05","pubTimestamp":1740485100,"startTime":"0","endTime":"0","summary":"01辉瑞目前的困境众所周知，宇宙药厂辉瑞在新冠期间靠疫苗和特效药发了横财，并且在2024年，它都是制药业务板块营收最高的MNC。排名第一的是派柏西利，治疗乳腺癌的CDK4/6抑制剂，小分子爆款单品的代表，排名第二的是恩杂鲁胺，治疗前列腺癌的抗雄激素受体小分子。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226124834abdd4ad3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226124834abdd4ad3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1066053197.SGD","IE00BFTCPJ56.SGD","SG9999013999.USD","LU1116320901.HKD","LU0170899867.USD","BK4550","BK4599","LU2023250843.SGD","LU1023059063.AUD","LU0266013472.USD","LU1037948897.HKD","LU2089984988.USD","LU1894683264.USD","LU0320765489.SGD","MRK","BK4588","LU2468319806.SGD","LU1291159041.SGD","SG9999002224.SGD","IE00BSNM7G36.USD","PFE","LU1093756325.SGD","SG9999014575.USD","SMMT","LU0203347892.USD","SG9999001176.USD","SGXZ57979304.SGD","BK4568","LU0208291251.USD","BK4139","BK4592","LU0225284248.USD","LU1983299246.USD","LU1934455277.USD","IE00BJJMRZ35.SGD","LU2361044949.HKD","LU2361045086.USD","LU0211331839.USD","LU1934455863.HKD","LU1585245621.USD","LU0058720904.USD","IE00BJT1NW94.SGD","LU1989772840.SGD","LU1162221912.USD","LU0456855351.SGD","LU2106854487.HKD","LU0070302665.USD","SG9999001176.SGD","LU0238689110.USD","LU0006306889.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155323570","title":"异动解读 | Summit Therapeutics PLC盘中大跌5.02%,与辉瑞临床试验合作引发机会","url":"https://stock-news.laohu8.com/highlight/detail?id=1155323570","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155323570?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:33","pubTimestamp":1740407613,"startTime":"0","endTime":"0","summary":"Summit Therapeutics PLC在今天的盘中交易中大跌5.02%,引起了市场的广泛关注。\n\n据报道,这家生物制药公司与辉瑞公司建立了临床试验合作关系,导致其股价在盘中出现大幅波动。投资者对于该合作关系所带来的发展机遇持谨慎乐观态度。\n\n一方面,与辉瑞这样的医药巨头建立合作无疑为Summit Therapeutics PLC的药物研发注入了新的动力。但另一方面,临床试验的结果以及双方的深度合作前景仍存在不确定性,从而引发了投资者的担忧情绪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727669","title":"Summit Therapeutics Inc.盘中异动 急速下跌6.24%报20.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727669","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513727669?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:31","pubTimestamp":1740407495,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分，Summit Therapeutics Inc.股票出现波动，股价急速下挫6.24%。截至发稿，该股报20.74美元/股，成交量38.2287万股，换手率0.05%，振幅3.71%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223136962e9879&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223136962e9879&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SMMT","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167008038","title":"异动解读 | SMMT股价盘前大涨近12%，业绩好于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1167008038","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167008038?lang=zh_cn&edition=full","pubTime":"2025-02-24 19:22","pubTimestamp":1740396136,"startTime":"0","endTime":"0","summary":"Summit Therapeutics PLC（SMMT）今日盘前股价大涨近12%，引发市场关注。\n\n公司财报显示，SMMT最新一季（2024财年第四季度）每股调整后亏损0.07美元，好于分析师一致预期的0.08美元亏损。公司业绩表现优于预期，可能是推动其股价大涨的主因。\n\n投资者对公司业绩向好的前景表示欢迎，体现在股价的大涨之中。不过，盘前数据往往也会随着盘中行情而发生变化，SMMT股价能否继续保持强劲表现还有待进一步观察。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | SMMT股价盘前大涨近12%，业绩好于预期","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183665713","title":"Summit Therapeutics 2024财年第四季度调整后每股亏损$(0.07)，超过预期的$(0.08)","url":"https://stock-news.laohu8.com/highlight/detail?id=1183665713","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183665713?lang=zh_cn&edition=full","pubTime":"2025-02-24 19:20","pubTimestamp":1740396034,"startTime":"0","endTime":"0","summary":"Summit Therapeutics（纳斯达克股票代码：SMMT）报告季度每股亏损$(0.07)，超过分析师一致预期的$(0.08)，增幅12.5%。以上内容来自Benzinga Earnings专栏，原文如下：Summit $Therapeutics(LENZ)$ (NASDAQ:SMMT) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08) by 12.5 percent.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMF","LENZ","SMMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513495212","title":"Summit Therapeutics Inc.盘中异动 临近收盘股价大跌5.03%报21.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513495212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513495212?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:43","pubTimestamp":1740170611,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时43分，Summit Therapeutics Inc.股票出现异动，股价快速下挫5.03%。截至发稿，该股报21.90美元/股，成交量256.472万股，换手率0.35%，振幅9.76%。Summit Therapeutics Inc.股票所在的生物技术行业中，整体涨幅为0.34%。Summit Therapeutics Inc.公司简介：Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222044331abd7fad9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222044331abd7fad9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SMMT","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.smmttx.com","stockEarnings":[{"period":"1week","weight":-0.1941},{"period":"1month","weight":0.2823},{"period":"3month","weight":0.3593},{"period":"6month","weight":0.1406},{"period":"1year","weight":-0.1182},{"period":"ytd","weight":0.2156}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.1224},{"period":"3month","weight":0.0234},{"period":"6month","weight":0.0469},{"period":"1year","weight":0.292},{"period":"ytd","weight":0.0437}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Summit Therapeutics Inc.于2013年11月22日在英格兰和威尔士注册成立，特拉华州的一家公司（“New Summit”）已成为该公司的后续发行方。该公司是一家生物制药公司，专注于发现、开发和商业化对患者、医生、护理人员和社会友好的药物疗法，旨在提高生活质量，延长潜在寿命，并解决严重的未满足的医疗需求。该公司的候选产品管线的设计目标是成为肿瘤治疗领域中对患者友好的、新时代的标准护理药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.093233},{"month":2,"riseRate":0.454545,"avgChangeRate":0.0357},{"month":3,"riseRate":0.454545,"avgChangeRate":0.039344},{"month":4,"riseRate":0.5,"avgChangeRate":0.041718},{"month":5,"riseRate":0.545455,"avgChangeRate":0.099475},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.086722},{"month":7,"riseRate":0.636364,"avgChangeRate":0.088383},{"month":8,"riseRate":0.454545,"avgChangeRate":-0.007003},{"month":9,"riseRate":0.363636,"avgChangeRate":0.075404},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.047867},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.015842},{"month":12,"riseRate":0.454545,"avgChangeRate":0.356783}],"exchange":"NASDAQ","name":"Summit Therapeutics PLC","nameEN":"Summit Therapeutics PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Summit Therapeutics PLC(SMMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Summit Therapeutics PLC(SMMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Summit Therapeutics PLC,SMMT,Summit Therapeutics PLC股票,Summit Therapeutics PLC股票老虎,Summit Therapeutics PLC股票老虎国际,Summit Therapeutics PLC行情,Summit Therapeutics PLC股票行情,Summit Therapeutics PLC股价,Summit Therapeutics PLC股市,Summit Therapeutics PLC股票价格,Summit Therapeutics PLC股票交易,Summit Therapeutics PLC股票购买,Summit Therapeutics PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Summit Therapeutics PLC(SMMT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Summit Therapeutics PLC(SMMT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}